{"id":"W2107216509","doi":"10.1136/annrheumdis-2012-202865","title":"Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal General Hospital; McGill University Health Centre","funders":"National Center for Advancing Translational Sciences; GlaxoSmithKline","keywords":"Belimumab; Medicine; Placebo; Internal medicine; Quality of life (healthcare); Randomized controlled trial; Systemic lupus erythematosus; Adverse effect; Physical therapy; B-cell activating factor; Immunology; Antibody; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004390781,0.0004811549,0.004141578,0.0002961433,0.0001074909,0.00006014815,0.0005766219,0.0001311075,0.0001142482],"category_scores_gemma":[0.005043942,0.0002184158,0.0004947188,0.0008340849,0.0003812436,0.0002315379,0.0001524056,0.0002606519,0.00001367486],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002357063,"about_ca_system_score_gemma":0.001248885,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006355427,"about_ca_topic_score_gemma":0.00008324418,"domain_scores_codex":[0.9887622,0.003833285,0.004389289,0.0005131075,0.001860329,0.0006418143],"domain_scores_gemma":[0.9870518,0.006927397,0.003433594,0.001339144,0.0008950746,0.0003530278],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1416635,0.002471859,0.8422759,0.003615974,0.002530695,0.000005167959,0.004492044,0.000338007,0.0002084707,0.00007457622,0.0009207199,0.00140309],"study_design_scores_gemma":[0.519835,0.00101579,0.4359058,0.03680276,0.0002365646,0.00003624166,0.003925999,0.001245539,0.0002679187,0.0003706006,0.000001424636,0.0003563772],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9730171,0.009433484,0.00001663674,0.0009211568,0.0001839699,0.01610897,0.0002419364,0.00003296069,0.00004379398],"genre_scores_gemma":[0.9984795,0.0003723214,0.00002940938,0.0001743914,0.00002218845,0.000713471,0.00006811036,0.00006292701,0.00007765167],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4063701,"threshold_uncertainty_score":0.9607547,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0410180639309466,"score_gpt":0.313622220978431,"score_spread":0.2726041570474844,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}